| Item Type | Name |
|
Concept
|
Bacterial Proteins
|
|
Concept
|
Nerve Tissue Proteins
|
|
Concept
|
Heat-Shock Proteins
|
|
Concept
|
Plant Proteins
|
|
Concept
|
Protozoan Proteins
|
|
Concept
|
Apoptosis Regulatory Proteins
|
|
Concept
|
Mitochondrial Proteins
|
|
Concept
|
Recombinant Proteins
|
|
Concept
|
Ribosomal Proteins
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Carrier Proteins
|
|
Concept
|
Luminescent Proteins
|
|
Concept
|
Recombinant Fusion Proteins
|
|
Concept
|
Adaptor Proteins, Vesicular Transport
|
|
Concept
|
Maltose-Binding Proteins
|
|
Academic Article
|
Measurement of the efficacy of vaccines and antimicrobial therapy against infection with Toxoplasma gondii.
|
|
Academic Article
|
Expression, purification and crystallization of the Plasmodium falciparum enoyl reductase.
|
|
Academic Article
|
Delivery of antimicrobials into parasites.
|
|
Academic Article
|
Evidence for mitochondrial-derived alternative oxidase in the apicomplexan parasite Cryptosporidium parvum: a potential anti-microbial agent target.
|
|
Academic Article
|
The unusual mitochondrial compartment of Cryptosporidium parvum.
|
|
Academic Article
|
Expression, purification and preliminary crystallographic analysis of the Toxoplasma gondii enoyl reductase.
|
|
Academic Article
|
Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents.
|
|
Academic Article
|
Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection.
|
|
Academic Article
|
Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.
|
|
Academic Article
|
T. gondii RP promoters & knockdown reveal molecular pathways associated with proliferation and cell-cycle arrest.
|
|
Academic Article
|
NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells.
|
|
Academic Article
|
Identification of a sporozoite-specific antigen from Toxoplasma gondii.
|
|
Academic Article
|
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.
|
|
Academic Article
|
Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.
|
|
Academic Article
|
Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.
|
|
Academic Article
|
Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections.
|
|
Academic Article
|
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway.
|
|
Academic Article
|
Deletion of the propeptide of apolipoprotein A-I impairs exit of nascent apolipoprotein A-I from the endoplasmic reticulum.
|
|
Academic Article
|
Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides.
|
|
Academic Article
|
Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.
|
|
Academic Article
|
Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove.
|
|
Academic Article
|
CSGID Solves Structures and Identifies Phenotypes for Five Enzymes in Toxoplasma gondii.
|
|
Concept
|
NLR Proteins
|
|
Grant
|
NOVEL APICOMPLEXAN METABOLISM AND ORGANELLE TRANSIT
|
|
Grant
|
CTL IMMUNE RESPONSE TO INGESTED TOXOPLASMA
|
|
Grant
|
Treatment of Congenital Toxoplasmosis
|
|
Grant
|
Optimizing Inhibitors of T. gondii ENR
|
|
Grant
|
Towards a Vaccine to Prevent Toxoplasmosis
|